Chemicals

2-Bromo-4′-chloroacetophenone

We are 2-Bromo-4′-chloroacetophenone CAS:536-38-9 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Product Name: 2-Bromo-4'-chloroacetophenone

CAS No.: 536-38-9

Synonym: 2-Bromo-1-(4-chlorophenyl)ethanone

4'-Chloro-2-Bromoacetophenone

4-Chlorophenacyl Bromide

Formula: C8H6BrClO

MW: 233.49

Density: 1.598g/cm3

Boiling point: 289.7ºC at 760mmHg

Melting point: 95-99ºC

Flash point: 129ºC

Stability: Stable at room temperature in closed containers under normal storage and handling conditions.

Export Info

HS Code: 2914399090

UN No.: UN3261

Hazard class: 8

Packing level: III

Specification

Appearance: White to light yellow solid

Purity: ≥99.0%

Moisture: ≤0.50%

Application

Organic synthesis intermediate.

Pharmaceutical intermediate.

Intermediate of Tolvaptan.

Packaging

250kg/barrel, can also be packaged according to customer requirements.

Storage

Store in a cool, ventilated warehouse.

Keep away from fire and heat.

The temperature should not exceed 37 °C.

2-Bromo-4'-chloroacetophenone

Related News: The foundational patent, which expires in 2034, is owned by MSK and is licensed exclusively to Fate Therapeutics for all human therapeutic uses.1-Naphthyl acetonitrile Optimize the reaction and improve the production process to reduce the production cost. At the same time, strengthen the determination and analysis of impurities to improve product quality.56-40-6 Optimize the reaction and improve the production process to reduce the production cost. At the same time, strengthen the determination and analysis of impurities to improve product quality.(3R, 4S, 5R, 6R) -3,4,5-tris (trimetilsililoxi) -6- (trimetilsililoximetil) oxan-2-ona CAS:32384-65-9 Optimize the reaction and improve the production process to reduce the production cost. At the same time, strengthen the determination and analysis of impurities to improve product quality.Patents covering oral and injectable rigosertib have been issued in the US and are expected to provide coverage until at least 2037.

Product Name
poly(methylvinylether/maleic acid) mixed salts copolymer Cas:62386-95-2	View Details
2,4-Dichloro-3,5-dinitrobenzotrifluoride	View Details
ethanone, 1-(2-hydroxy-5-nonylphenyl)-, oxime Cas:59344-62-6	View Details